122 related articles for article (PubMed ID: 36690302)
1. Survival prediction for stage I-IIIA non-small cell lung cancer using deep learning.
Zheng S; Guo J; Langendijk JA; Both S; Veldhuis RNJ; Oudkerk M; van Ooijen PMA; Wijsman R; Sijtsema NM
Radiother Oncol; 2023 Mar; 180():109483. PubMed ID: 36690302
[TBL] [Abstract][Full Text] [Related]
2. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.
Hosny A; Parmar C; Coroller TP; Grossmann P; Zeleznik R; Kumar A; Bussink J; Gillies RJ; Mak RH; Aerts HJWL
PLoS Med; 2018 Nov; 15(11):e1002711. PubMed ID: 30500819
[TBL] [Abstract][Full Text] [Related]
3. Prognostication of lung adenocarcinomas using CT-based deep learning of morphological and histopathological features: a retrospective dual-institutional study.
Lee T; Lee KH; Lee JH; Park S; Kim YT; Goo JM; Kim H
Eur Radiol; 2024 May; 34(5):3431-3443. PubMed ID: 37861801
[TBL] [Abstract][Full Text] [Related]
4. Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging.
Xu Y; Hosny A; Zeleznik R; Parmar C; Coroller T; Franco I; Mak RH; Aerts HJWL
Clin Cancer Res; 2019 Jun; 25(11):3266-3275. PubMed ID: 31010833
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.
Fried DV; Tucker SL; Zhou S; Liao Z; Mawlawi O; Ibbott G; Court LE
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):834-42. PubMed ID: 25220716
[TBL] [Abstract][Full Text] [Related]
6. Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis.
Yu L; Tao G; Zhu L; Wang G; Li Z; Ye J; Chen Q
BMC Cancer; 2019 May; 19(1):464. PubMed ID: 31101024
[TBL] [Abstract][Full Text] [Related]
7. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
8. A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Robinson EJ; Orton M; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
EBioMedicine; 2022 Mar; 77():103911. PubMed ID: 35248997
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
Blanc-Durand P; Campedel L; Mule S; Jegou S; Luciani A; Pigneur F; Itti E
Eur Radiol; 2020 Jun; 30(6):3528-3537. PubMed ID: 32055950
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
[TBL] [Abstract][Full Text] [Related]
11. [Value of surgery for stage IIIa non-small cell lung cancer].
Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
[TBL] [Abstract][Full Text] [Related]
13. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
14. Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy.
Avanzo M; Gagliardi V; Stancanello J; Blanck O; Pirrone G; El Naqa I; Revelant A; Sartor G
Med Phys; 2021 Oct; 48(10):6257-6269. PubMed ID: 34415574
[TBL] [Abstract][Full Text] [Related]
15. Integration of Risk Survival Measures Estimated From Pre- and Posttreatment Computed Tomography Scans Improves Stratification of Patients With Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
Jiao Z; Li H; Xiao Y; Aggarwal C; Galperin-Aizenberg M; Pryma D; Simone CB; Feigenberg SJ; Kao GD; Fan Y
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1647-1656. PubMed ID: 33333202
[TBL] [Abstract][Full Text] [Related]
16. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
17. Combining handcrafted features with latent variables in machine learning for prediction of radiation-induced lung damage.
Cui S; Luo Y; Tseng HH; Ten Haken RK; El Naqa I
Med Phys; 2019 May; 46(5):2497-2511. PubMed ID: 30891794
[TBL] [Abstract][Full Text] [Related]
18. Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images.
Tian P; He B; Mu W; Liu K; Liu L; Zeng H; Liu Y; Jiang L; Zhou P; Huang Z; Dong D; Li W
Theranostics; 2021; 11(5):2098-2107. PubMed ID: 33500713
[No Abstract] [Full Text] [Related]
19. Preoperative CT-based Deep Learning Model for Predicting Disease-Free Survival in Patients with Lung Adenocarcinomas.
Kim H; Goo JM; Lee KH; Kim YT; Park CM
Radiology; 2020 Jul; 296(1):216-224. PubMed ID: 32396042
[TBL] [Abstract][Full Text] [Related]
20. Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer.
Zhong Y; She Y; Deng J; Chen S; Wang T; Yang M; Ma M; Song Y; Qi H; Wang Y; Shi J; Wu C; Xie D; Chen C;
Radiology; 2022 Jan; 302(1):200-211. PubMed ID: 34698568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
